Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials-Reference-Cited by-同舟云学术

Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials

Published:2019-03 Issue:3 Volume:19 Page:265-274
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Gerding Dale N,Cornely Oliver A,Grill Simon,Kracker Hilke,Marrast Anne Claire,Nord Carl Erik,Talbot George H,Buitrago Martha,Gheorghe Diaconescu Iulian,Murta de Oliveira Claudia,Preotescu Liliana,Pullman John,Louie Thomas J,Wilcox Mark H

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference25 articles.

1. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection;Debast;Clin Microbiol Infect,2014

2. Update of treatment algorithms for Clostridium difficile infection;Ooijevaar;Clin Microbiol Infect,2018

3. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA);McDonald;Clin Infect Dis,2018

4. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials;Johnson;Clin Infect Dis,2014

5. C. difficile infection: changing epidemiology and management paradigms;Vindigni;Clin Transl Gastroenterol,2015

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in fecal microbiota transplantation for Clostridium difficile infection-associated diarrhea after kidney transplantation;Frontiers in Microbiomes;2024-07-16

2. Fighting against Clostridioides difficile infection: Current medications;International Journal of Antimicrobial Agents;2024-07

3. Discovery and Structure–Activity Relationship of Cadazolid: A First-In-Class Quinoxolidinone Antibiotic for the Treatment of Clostridioides difficile Infection;Journal of Medicinal Chemistry;2024-05-16

4. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

5. In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy;Antimicrobial Agents and Chemotherapy;2024-03-06